Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters - A randomized controlled trial

被引:79
作者
Darouiche, RO
Berger, DH
Khardori, N
Robertson, CS
Wall, MJ
Metzler, MH
Shah, S
Mansouri, MD
Cerra-Stewart, C
Versalovic, J
Reardon, MJ
Raad, II
机构
[1] Baylor Coll Med, Ctr Prostheses Infect, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Pathol, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
[6] So Illinois Univ, Sch Med, Dept Med, Springfield, IL 62708 USA
[7] Univ Missouri, Dept Surg, Columbia, MO USA
[8] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA
关键词
D O I
10.1097/01.sla.0000171874.29934.61
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: We sought to compare the impact of antimicrobial impregnation to that of tunneling of long-term central venous catheters on the rates of catheter colonization and catheter-related bloodstream infection. Summary Background Data: Tunneling of catheters constitutes a standard of care for preventing infections associated with long-term vascular access. Although antimicrobial coating of short-term central venous catheters has been demonstrated to protect against catheter-related bloodstream infection, the applicability of this preventive approach to long-term vascular access has not been established. Methods: A prospective, randomized clinical trial in 7 university-affiliated hospitals of adult patients who required a vascular access for >= 2 weeks. Patients were randomized to receive a silicone central venous catheter that was either impregnated with minocycline and rifampin or tunneled. The occurrence of catheter colonization and catheter-related bloodstream infection was determined. Results: Of a total of 351 inserted catheters, 346 (186 antimicrobial-impregnated and 160 tunneled) were analyzed for catheter-related bloodstream infection. Clinical characteristics were comparable in the 2 study groups, but the antimicrobial-impregnated catheters remained in place for a shorter period of time (mean, 30.2 versus 43.8 days). Antimicrobial-impregnated catheters were as likely to be colonized as tunneled catheters (7.9 versus 6.3 per 1000 catheter-days). Bloodstream infection was 4 times less likely to originate from anti microbial-impregnated than from tunneled catheters (0.36 versus 1.43 per 1000 catheter-days). Conclusions: Antimicrobial impregnation of long-term central venous catheters may help obviate the need for tunneling of catheters.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 32 条
[1]   LACK OF CLINICAL BENEFIT FROM SUBCUTANEOUS TUNNEL INSERTION OF CENTRAL VENOUS CATHETERS IN IMMUNOCOMPROMISED PATIENTS [J].
ANDRIVET, P ;
BACQUER, A ;
NGOC, CV ;
FERME, C ;
LETINIER, JY ;
GAUTIER, H ;
GALLET, CB ;
BRUNBUISSON, C .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (02) :199-206
[2]   PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].
BLACKWELDER, WC .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353
[3]   Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: Efficacy and low risk of developing staphylococcal resistance [J].
Chatzinikolaou, I ;
Hanna, H ;
Graviss, L ;
Chaiban, G ;
Perego, C ;
Arbuckle, R ;
Champlin, R ;
Darouiche, R ;
Samonis, G ;
Raad, I .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (12) :961-963
[4]   Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: A prospective, randomized study [J].
Chatzinikolaou, L ;
Finkel, K ;
Hanna, H ;
Boktour, M ;
Foringer, J ;
Ho, T ;
Raad, I .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (05) :352-357
[5]   The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices [J].
Crnich, CJ ;
Maki, DG .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1232-1242
[6]   The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices [J].
Crnich, CJ ;
Maki, DG .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) :1362-1368
[7]   A comparison of two antimicrobial-impregnated central venous catheters [J].
Darouiche, RO ;
Raad, II ;
Heard, SO ;
Thornby, JI ;
Wenker, OC ;
Gabrielli, A ;
Berg, J ;
Khardori, N ;
Hanna, H ;
Hachem, R ;
Harris, RL ;
Mayhall, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :1-8
[8]  
DECICCO M, 1989, LANCET, V2, P1258, DOI 10.1016/S0140-6736(89)91861-8
[9]   Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit [J].
Dimick, JB ;
Pelz, RK ;
Consunji, R ;
Swoboda, SM ;
Hendrix, CW ;
Lipsett, PA .
ARCHIVES OF SURGERY, 2001, 136 (02) :229-234
[10]   THE IDLE INTRAVENOUS CATHETER [J].
LEDERLE, FA ;
PARENTI, CM ;
BERSKOW, LC ;
ELLINGSON, KJ .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (09) :737-738